- Protease-Inhibitor (PI) Triple Therapy (TT) in Mildly Decompensated Cirrhotics: Predictors of Treatment Discontinuation, Worsening Decompensation and Sustained Virologic ResponseSaxena Varun; Yee Helen S; Catalli Lisa; Wayne Elizabeth M; Chua Joshua; Monto Alexander; Terrault Norah64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, 2013-11-01 To 2013-11-05.
- Higher Sustained Virologic Response (SVR-12) Achievable in Liver Transplant (LT) Recipients with Hepatitis C (HCV) Treated with Protease Inhibitor (PI) Triple Therapy (TT)Stravitz R Todd; Levitsky Josh; Dodge Jennifer L; Saxena Varun; Burton James R; Verna Elizabeth C; O'Leary Jacqueline G; Parikh Neehar D; Everson Gregory T; Brown Robert S; Trotter James; Terrault Norah64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, 2013-11-01 To 2013-11-05.被引 3
- Advances in Long-Acting Agents for the Treatment of HIV InfectionAadia I., Rana; Jose R., Castillo-Mancilla; Karen T., Tashima; Raphael L., LandovitzDrugs, 2020, 80(6): 535-545.被引 4
期刊论文
Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
3阅读
